OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
Webinar on Verified Antigen
Verified Antigen Webinar

Browse all lysates


spacer
OriGene in recent publications
ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN Hum. Mol. Genet., May 2013; 10.1093/hmg/ddt222. [FUS]
ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN Hum. Mol. Genet., May 2013; 10.1093/hmg/ddt222. [SMN]
Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer British Journal of Cancer doi:10.1038/bjc.2013.215 [PODXL ]
Oral Abstracts 3: Adolescent and Young Adult • O13. Hypermobility is a Risk Factor for Musculoskeletal Pain in Adolescence: Findings From a Prospective Cohort Study Rheumatology, Apr 2013; 52: i33 - i43. [NXP2]
View All Citations >>

spacer

88 Lysate belong to pathway "arrhythmogenic right ventricular cardiomyopathy (arvc)"

divider

  Page: 1 of 5 
Direct Download
spacer
SKUAccnSymbolDescriptionShipping
LY400004NM_000023SGCATransient overexpression lysate of sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) (SGCA), transcript variant 1 5 days
LY400039NM_000117EMDTransient overexpression lysate of emerin (EMD) 5 days
LY400061NM_000165GJA1Transient overexpression lysate of gap junction protein, alpha 1, 43kDa (GJA1) 5 days
LY400075NM_000210ITGA6Transient overexpression lysate of integrin, alpha 6 (ITGA6), transcript variant 2 5 days
LY400093NM_000232SGCBTransient overexpression lysate of sarcoglycan, beta (43kDa dystrophin-associated glycoprotein) (SGCB) 5 days
LY400125NM_000337SGCDTransient overexpression lysate of sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) (SGCD), transcript variant 1 5 days
LY400240NM_000726CACNB4Transient overexpression lysate of calcium channel, voltage-dependent, beta 4 subunit (CACNB4), transcript variant 2 5 days
LY400316NM_000885ITGA4Transient overexpression lysate of integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) (ITGA4) 5 days
LY400324NM_000888ITGB6Transient overexpression lysate of integrin, beta 6 (ITGB6) 5 days
LY400325NM_000889ITGB7Transient overexpression lysate of integrin, beta 7 (ITGB7) 5 days
LY400447NM_001102ACTN1Transient overexpression lysate of actinin, alpha 1 (ACTN1), transcript variant 2 5 days
LY400708NM_001903CTNNA1Transient overexpression lysate of catenin (cadherin-associated protein), alpha 1, 102kDa (CTNNA1) 5 days
LY400713NM_001927DESTransient overexpression lysate of desmin (DES) 5 days
LY400802NM_002203ITGA2Transient overexpression lysate of integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) (ITGA2) 5 days
LY400803NM_002205ITGA5Transient overexpression lysate of integrin, alpha 5 (fibronectin receptor, alpha polypeptide) (ITGA5) 5 days
LY400804NM_002207ITGA9Transient overexpression lysate of integrin, alpha 9 (ITGA9) 5 days
LY400805NM_002211ITGB1Transient overexpression lysate of integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) (ITGB1), transcript variant 1A 5 days
LY400807NM_002230JUPTransient overexpression lysate of junction plakoglobin (JUP), transcript variant 1 5 days
LY401204NM_003637ITGA10Transient overexpression lysate of integrin, alpha 10 (ITGA10) 5 days
LY402529NM_016269LEF1Transient overexpression lysate of lymphoid enhancer-binding factor 1 (LEF1), transcript variant 1 5 days

 
pattern
Inc 5000 Healthcare Company Copyright © 2013 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title